DAV132

DEVICE3 trials

Sponsors

Da Volterra

Conditions

Clostridium Difficile InfectionHealthyHealthy Subjects

Phase 1

Safety and Efficacy Study of DAV132 in Healthy Volunteers

CompletedNCT02176005

Da VolterraHealthy

Start: 2014-03-31End: 2014-12-31Updated: 2020-02-28

Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers

CompletedNCT02917200

Da VolterraHealthy Subjects

Start: 2016-05-11End: 2016-12-02Updated: 2017-09-12

Unknown Phase

Safety and Efficacy of DAV132 in Patients at High-Risk for Clostridium Difficile Infection (CDI)

CompletedNCT03710694

Da VolterraClostridium Difficile Infection

Start: 2018-10-31End: 2019-08-09Updated: 2019-08-30

Related Papers

Protection of the Human Gut Microbiome From Antibiotics

The Journal of Infectious Diseases2017-11-19158 citations